Phosphatidylserine: quantitative EEG effects in healthy volunteers.
Eight healthy paid male volunteers (age: 21-28 years, mean: 24.5 +/- 1.7 years; weight 62-79 kg) were administered via intravenous infusion (3 min) acute 25-, 50-, and 75-mg doses of phosphatidylserine, or matching placebo in a latin-square design. Multichannel EEG recordings were performed in baseline conditions, during intravenous infusion, and 10, 30, 90, 180, and 360 min after drug/placebo administration. Blood pressure, heart rate, critical flicker-fusion frequency, and the subjects' performance at immediate and short-term retention tests were assessed after each electroencephalographic (EEG) recording. The EEG signal was quantified off-line by power spectral analysis, and bidimensional scalp maps were produced for each EEG variable. Descriptive statistical comparisons among subjects and between pre- and postdrug EEG recordings allowed the detection of systematic EEG changes (notably increment of the power on the 'alpha' frequency, which was restricted to the anterior electrode deviations at the 50-mg dose and the widespread to the whole scalp at the highest dose, and increase of the signal total power) in the absence of significant modifications of the subjects' neuropsychological status.
Rosadini
G
G
Institute of Neurophysiopathology, University, Genova, Italy.
Sannita
W G
WG
Nobili
F
F
Cenacchi
T
T
D000328:Adult; D001519:Behavior / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D001931:Brain Mapping; D004569:Electroencephalography / Q000187:drug effects* / Q000379:methods; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D010718:Phosphatidylserines / Q000494:pharmacology*; D012016:Reference Values
D010718:Phosphatidylserines